Edward White
Stock Analyst at HC Wainwright & Co.
(1.15)
# 3,325
Out of 4,670 analysts
353
Total ratings
25.33%
Success rate
-10.68%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PBYI Puma Biotechnology | Reiterates: Buy | $7 | $3.00 | +133.33% | 18 | Nov 20, 2024 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $15 | $6.16 | +143.51% | 3 | Nov 18, 2024 | |
| ACET Adicet Bio | Reiterates: Neutral | n/a | $0.90 | - | 19 | Nov 18, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $49 → $51 | $16.09 | +216.97% | 27 | Nov 18, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $0.90 | - | 6 | Nov 15, 2024 | |
| CRIS Curis | Reiterates: Buy | $20 | $4.03 | +396.28% | 16 | Nov 15, 2024 | |
| IFRX InflaRx | Reiterates: Buy | $8 | $2.08 | +284.62% | 21 | Nov 15, 2024 | |
| AURA Aura Biosciences | Reiterates: Buy | $22 | $8.95 | +145.81% | 4 | Nov 14, 2024 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $0.58 | - | 11 | Nov 13, 2024 | |
| CMRX Chimerix | Reiterates: Buy | $11 | $0.90 | +1,122.22% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4.25 | $4.31 | -1.39% | 15 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $12.42 | +133.49% | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.81 | +398.22% | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.85 | +728.40% | 25 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $35.07 | +56.83% | 29 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $10.13 | - | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.54 | +123.29% | 21 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $5 | $2.31 | +116.45% | 9 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $8.00 | +112.50% | 12 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $4.43 | +351.47% | 30 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $3.13 | +91.69% | 13 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.52 | +667.61% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.32 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $2.47 | +709.72% | 4 | Jun 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.70 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $2.04 | +1,272.55% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $26.79 | +11.98% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $2.29 | +424.02% | 2 | Mar 6, 2018 |
Puma Biotechnology
Nov 20, 2024
Reiterates: Buy
Price Target: $7
Current: $3.00
Upside: +133.33%
Larimar Therapeutics
Nov 18, 2024
Reiterates: Buy
Price Target: $15
Current: $6.16
Upside: +143.51%
Adicet Bio
Nov 18, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Syndax Pharmaceuticals
Nov 18, 2024
Maintains: Buy
Price Target: $49 → $51
Current: $16.09
Upside: +216.97%
60 Degrees Pharmaceuticals
Nov 15, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Curis
Nov 15, 2024
Reiterates: Buy
Price Target: $20
Current: $4.03
Upside: +396.28%
InflaRx
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $2.08
Upside: +284.62%
Aura Biosciences
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $8.95
Upside: +145.81%
Bolt Biotherapeutics
Nov 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Chimerix
Nov 11, 2024
Reiterates: Buy
Price Target: $11
Current: $0.90
Upside: +1,122.22%
Nov 8, 2024
Reiterates: Neutral
Price Target: $4.25
Current: $4.31
Upside: -1.39%
Nov 8, 2024
Reiterates: Buy
Price Target: $29
Current: $12.42
Upside: +133.49%
Nov 6, 2024
Reiterates: Buy
Price Target: $14
Current: $2.81
Upside: +398.22%
Nov 6, 2024
Reiterates: Buy
Price Target: $7
Current: $0.85
Upside: +728.40%
Nov 5, 2024
Maintains: Buy
Price Target: $49 → $55
Current: $35.07
Upside: +56.83%
Oct 24, 2024
Initiates: Neutral
Price Target: n/a
Current: $10.13
Upside: -
Oct 16, 2024
Reiterates: Buy
Price Target: $28
Current: $12.54
Upside: +123.29%
Oct 14, 2024
Maintains: Buy
Price Target: $15 → $5
Current: $2.31
Upside: +116.45%
Oct 11, 2024
Maintains: Buy
Price Target: $18 → $17
Current: $8.00
Upside: +112.50%
Oct 11, 2024
Maintains: Buy
Price Target: $23 → $20
Current: $4.43
Upside: +351.47%
Aug 12, 2024
Reiterates: Buy
Price Target: $6
Current: $3.13
Upside: +91.69%
Aug 7, 2024
Reiterates: Buy
Price Target: $4
Current: $0.52
Upside: +667.61%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Jun 30, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $2.47
Upside: +709.72%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $2.04
Upside: +1,272.55%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $26.79
Upside: +11.98%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $2.29
Upside: +424.02%